Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity.
about
Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domainMicro- and nanodevices integrated with biomolecular probes.A Review of Cell Adhesion Studies for Biomedical and Biological Applications.Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease."Do-it-yourself in vitro vasculature that recapitulates in vivo geometries for investigating endothelial-blood cell interactions"Dynamic deformability of sickle red blood cells in microphysiological flow.MEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivoBiomarkers and recent advances in the management and therapy of sickle cell diseasePhase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemiaInhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease miceMolecular mechanisms underlying synergistic adhesion of sickle red blood cells by hypoxia and low nitric oxide bioavailability.Heterogeneous red blood cell adhesion and deformability in sickle cell disease.Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.Cutaneous microvascular blood flow and reactivity in patients with homozygous sickle cell anaemia.Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpura.Severe thrombocytopenia in sickle cell crisis.Targeted quantitative phosphoproteomic analysis of erythrocyte membranes during blood bank storage.Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.Treating sickle cell disease by targeting HbS polymerizationGlycosylation inhibitors efficiently inhibit P-selectin-mediated cell adhesion to endothelial cellsIntercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium.Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications.Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial.A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.Peripheral vascular response to inspiratory breath hold in paediatric homozygous sickle cell diseaseSpecific binding of red blood cells to endothelial cells is regulated by nonadsorbing macromolecules.Molecular defect in the sickle erythrocyte skeleton. Abnormal spectrin binding to sickle inside-our vesiclesCharacterization of membrane homing receptors in two cloned murine hemopoietic progenitor cell linesDeconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytesDeveloping treatment for sickle cell disease.Monocyte protein signatures of disease severity in sickle cell anemia.Sickle red cell-endothelium interactions.The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)Morphologically homogeneous red blood cells present a heterogeneous response to hormonal stimulationBlood viscosity and the expression of inflammatory and adhesion markers in homozygous sickle cell disease subjects with chronic leg ulcers.Why Do We Need ADAMTS13?Anaesthetic management of the child with sickle cell disease.Quantification of sickle cells in the peripheral smear as a marker of disease severity.
P2860
Q24336588-0CA8D609-0AC3-4C61-A30C-F419F8BF6504Q26781371-032B4372-27F6-4099-8DD4-715FC130FBA2Q26801184-8C080615-3D32-4D46-94AB-3EE9BB04B0DFQ27303155-89AC478A-4A47-4016-A71D-57B4058A2B28Q27308776-7999956C-399A-4567-9592-CAEF3D732524Q27316518-F8707EAB-1EB6-4914-AB11-A30D3C106507Q27335195-85380D19-28FD-4277-8B31-CBBB27D3FED9Q28082462-E6CE93FA-4ECE-4AF0-9622-0854E46B592DQ28540243-07C0F4FC-390C-4CF0-B513-A77C7955A196Q30498050-BEEA041D-F7B9-43BF-BAD1-20ECAF7FD2FEQ30525565-8312C258-104F-4B9E-9639-E299032EBF52Q30574476-997C8D18-6123-4B6A-A780-8A666B9B801FQ30601237-64BD6E6C-39D5-4A26-B8D3-28F9061A54F5Q30830149-C8D6D8E1-FBEB-46AF-95E7-30C4437496EBQ33184356-D5CB689D-7BC3-436B-9CC0-36B115FA3F1DQ33345707-69876CC6-7F45-43A6-A067-B2D652C265BCQ33447717-AED2A016-8066-4014-89AF-22E43C1F2EE8Q33457255-22CE1588-EE8B-4D31-B982-1DFDA00E1A6BQ33574142-A5E912F5-C6B6-47D4-AADD-8B7CF679BF66Q33707352-82F036C1-E1EC-4142-A795-54F8BE707DADQ33778831-25F1B5C3-406C-4449-9CAC-0749D1501A8FQ33829064-747B8798-B39A-401E-AB87-0F2E5DD55280Q33854510-1DFB7DFF-C119-4134-9BD1-945463C17702Q33909764-80CF21BF-99F6-4EFC-BD5F-C1D9F5A66D97Q34038874-9A9CAE78-E05B-415C-9926-DD3AD5FE981EQ34290485-7FC67DAF-F4F1-4290-90EC-349EFC15BD79Q34412546-1BF67D94-0E79-472C-B13D-5F2402B58DF4Q34524564-30D4811D-3824-4650-BFE0-0A437184DAD5Q34568444-CD043002-E9D7-4C0D-9F81-6EA7B9B54F63Q34579250-72FC7082-766F-4D68-B0E7-51BC5A5CED2BQ34599206-2ABE679A-9146-401B-B3D7-7F6E8222B88EQ34628666-F4C707A3-8764-4C88-9534-DEF6821B0BCFQ34660975-C86EE2B6-C33C-42C7-9933-EB466E6E9E0AQ34686539-139AF137-07B3-492A-AD98-814C934F627FQ34734929-E94AAD42-581C-4CC3-8E7C-A890E5453114Q34807941-3BAEE148-072E-4574-8370-A254AC0346FFQ34901902-E1022413-5EA1-4BB6-AE05-031C7DEB38C8Q35062975-191F4934-B250-4E7B-A8D5-68FE855BD467Q35170873-207F9EF4-AA48-45E9-A2F0-88B8C482C3B8Q35527101-D219CB7F-C5E5-4B2C-82DF-9CDAF83CD0A6
P2860
Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Erythrocyte adherence to endot ...... terminant of disease severity.
@en
type
label
Erythrocyte adherence to endot ...... terminant of disease severity.
@en
prefLabel
Erythrocyte adherence to endot ...... terminant of disease severity.
@en
P2093
P1476
Erythrocyte adherence to endot ...... terminant of disease severity.
@en
P2093
P304
P356
10.1056/NEJM198005013021803
P407
P577
1980-05-01T00:00:00Z